The Value of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia with and without ASXL1-, RUNX1- and TP53 Mutations

Heidrich K, Middeke JM, Schaefer-Eckart K, Aulitzky WE, Einsele H, Mueller-Tidow C, Rösler W, Haenel M, Baldus CD, Fransecky L, Stoelzel F, Roellig C, Taube F, Kramer M, Stasik S, Neubauer A, Burchert A, Berdel WE, Stelljes M, Bug G, Ehninger G, Bornhaeuser M, Thiede C, Schetelig J (2020)


Publication Type: Conference contribution

Publication year: 2020

Journal

Publisher: SPRINGERNATURE

City/Town: LONDON

Pages Range: 27-28

Conference Proceedings Title: BONE MARROW TRANSPLANTATION

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Heidrich, K., Middeke, J.M., Schaefer-Eckart, K., Aulitzky, W.E., Einsele, H., Mueller-Tidow, C.,... Schetelig, J. (2020). The Value of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia with and without ASXL1-, RUNX1- and TP53 Mutations. In BONE MARROW TRANSPLANTATION (pp. 27-28). LONDON: SPRINGERNATURE.

MLA:

Heidrich, Katharina, et al. "The Value of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia with and without ASXL1-, RUNX1- and TP53 Mutations." Proceedings of the BONE MARROW TRANSPLANTATION LONDON: SPRINGERNATURE, 2020. 27-28.

BibTeX: Download